The stock market has begun 2012 with some gusto as the S&P 500 has risen 7 percent through mid-February.
Capsalus Corp. (OTCBB:WELL) has completed the acquisition of the stock of GeneWize Life Sciences, Inc., the wholly owned direct-selling subsidiary of GeneLink Biosciences, Inc. (OTCBB:GNLK), a leader in consumer genomics. The deal will provide immediate revenues.
Last year was eventful for many direct sellers, including some management shake-ups, continued economic uncertainty and a strengthening U.S. dollar that shed international sales for many. As 2012 begins, more big news certainly lies ahead.
As 2011 comes to a close and corporate boardrooms reflect upon the past year, there are some wildly varied perceptions of how Wall Street treated the direct selling sector over the past year.